Other Vaccines - Dominican Republic

Dominican Republic

Highlights

The revenue in the Other Vaccines market in the Dominican Republic is expected to reach US$24.98m in 2024.
It is projected to show an annual growth rate (CAGR 2024-2029) of 11.29%, leading to a market volume of US$42.65m by 2029.
When compared globally, United States is anticipated to generate the highest revenue of US$24.73bn in 2024.
The Dominican Republic has seen a rising demand for other vaccines, driven by an increasing focus on preventative healthcare.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Other Vaccines market in Dominican Republic has been experiencing significant growth in recent years.

Customer preferences: The Dominican Republic has a population of over 10 million people, and the demand for vaccines has been increasing due to a growing awareness of the importance of preventive healthcare. Customers in the country are becoming more health-conscious and are willing to invest in vaccines that can protect them from various diseases.

Trends in the market: One of the major trends in the Other Vaccines market in Dominican Republic is the increasing demand for travel vaccines. With the growth of the tourism industry in the country, more people are traveling to and from the Dominican Republic, which has led to a higher demand for vaccines that protect against diseases such as yellow fever, hepatitis A and B, and typhoid fever.Another trend in the market is the increasing demand for vaccines that protect against sexually transmitted diseases. The Dominican Republic has one of the highest rates of HIV/AIDS in the Caribbean, and this has led to a growing demand for vaccines that can prevent the disease.

Local special circumstances: One of the unique features of the Other Vaccines market in Dominican Republic is the presence of a large number of private healthcare providers. Many people in the country choose to use private healthcare providers rather than relying on the public healthcare system, and this has led to a higher demand for vaccines in the private sector.

Underlying macroeconomic factors: The Dominican Republic has a growing economy, and this has led to an increase in disposable income among the population. As people have more money to spend, they are more willing to invest in preventive healthcare measures such as vaccines. Additionally, the government of the Dominican Republic has been investing in healthcare infrastructure in recent years, which has helped to increase access to vaccines for the population.In conclusion, the Other Vaccines market in Dominican Republic is experiencing significant growth due to increasing customer preferences for preventive healthcare, trends such as the demand for travel and sexually transmitted disease vaccines, local special circumstances such as the presence of private healthcare providers, and underlying macroeconomic factors such as a growing economy and government investment in healthcare infrastructure.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.